Kala Pharmaceuticals (NSDQ:KALA) today priced its initial public offering of 6 million shares of common stock at $15.00 apiece. The IPO is slated to bring in nearly $90 million for the Waltham, Mass.-based company.
The offering, which is expected to close on July 25, includes a 30-day option for underwriters to buy up to 900,000 additional shares of common stock.
Get the full story at our sister site, Drug Delivery Business News.
The post Kala Pharmaceuticals prices $90m IPO appeared first on MassDevice.
from MassDevice http://ift.tt/2tjAQzQ
Cap comentari:
Publica un comentari a l'entrada